News

Lecture to Focus on ‘Facts vs. Fiction’ of COVID-19 Vaccines

A free livestreamed lecture by UArizona Health Sciences immunologist Dr. Deepta Bhattacharya offers an expert look at COVID-19 vaccines, variants and immunity.


Emphysema Immune Responses May Lead To New Treatments

With a $3.3 million grant from the National Institutes of Health, Dr. Francesca Polverino will investigate B cell responses in patients with emphysema.


Experts To Answer COVID-19 Vaccine Questions at Town Hall

Questions about COVID-19 vaccine safety, speed of vaccine development, side effects, efficacy and variants will be answered by at a free virtual town hall.


Predicting and Responding to Emerging Viruses and Pandemics

This VIRTUAL symposium brings together national and international experts in virus emergence, infectious disease, public health and policy to discuss how we prepare for and respond to coming pandemic threats.


Match Day Marks Next Step for Future Doctors

On Match Day, about 120 UArizona College of Medicine – Tucson students learned where they’ll launch their careers as new residents after graduation.


The dynamic duo: Dr. Felicia Goodrum (left) and Dr. James Alwine (right)
Press Release

Scientists at the University of Arizona have joined a national effort to educate the general public about COVID-19 vaccination


The Immunity, Inflammation and Aging Link: Building Better Defenses Against Disease

Immunobiology and UArizona Heal Sciences researchers are improving health by studying the interactions that govern the immune defense system against invading microbes.


More Answers to Your Questions About COVID-19 Vaccinations

Immunobiologist Dr. Deepta Bhattacharya answers common questions about what to expect after receiving the COVID-19 vaccine.


UArizona Health Sciences Excels in Latest Blue Ridge Rankings on NIH Funding

Increases in total National Institutes of Health funding have led to higher rankings for several colleges and departments.


UArizona Health Sciences COVID-19 Immunity Study to Test Vaccine Effectiveness, Enroll College Students

The AZ HEROES research study is expanding its scope to assess vaccine effectiveness, as well as increasing eligibility to include college students.


UArizona Researchers Develop Smartphone-Based COVID-19 Test

The new test aims to combine the speed of existing nasal swab antigen tests with the high accuracy of nasal swab PCR, or polymerase chain reaction, tests.


Statewide Antibody Testing Initiative Reaches Milestone, Expects Vaccine-Related Increase in Registrations

The antibody test developed at the UArizona Health Sciences can be used to confirm a positive antibody response after receiving a COVID-19 vaccine.


People and Programs on the Move at the UArizona College of Medicine – Tucson

AIDS women’s health award to Dr. Liz Connick; Liver Institute wins CDC designation; Dr. Julie Bauman co-chairs cancer prevention committee.


What You Need to Know About Pfizer's COVID-19 Vaccine

University of Arizona Health Sciences immunobiologist Dr. Deepta Bhattacharya says the COVID-19 vaccine is safe, and he will take it when it becomes available.


COVID-19 Dominates Top 10 UArizona Health Sciences News Stories of 2020

Antibody tests, groundbreaking research and community outreach are a few of the ways the University of Arizona Health Sciences met the test of a pandemic.


Joyce Hsin-Jung Wu, Microbiota Control Lung Th17 Cell Response and Plasticity Leading to Autoimmune Lung Disease, $1,776,972-National Heart, Lung, and Blood Institute


Drs. Bhattacharya and Worobey present


Dr. Michael Johnson shared lessons of flexibility and creativity with budding STEM professionals during the 5th Annual NIGMS Director’s Early Career Investigator Lecture.


Michael Kuhns, PhD, and Shio Kobayashi, PhD, a post-doctoral research fellow, study the basic science of T cell activation in the immune system, and they are using that knowledge to find potential


UArizona Health Sciences team takes T cell research to the next level

UArizona Health Sciences immunobiologists have created a five-module chimeric antigen receptor T cell that is showing early potential to fight Type 1 diabetes.


Pages